Wockhardt Ltd. - Research Center
532300 WOCKPHARMA Group (T) BSE data
Add to watchlist
| Results | |
| Statement | |
| More |
Capital structures
|
Capital structure
(Rs crore)
| From Year | To Year | Class Of Share | Authorized Capital | Issued Capital | Paid Up Shares (Nos) | Paid Up Face Value | Paid Up Capital |
|---|---|---|---|---|---|---|---|
| 2022 | 2023 | Equity Share | 125.00 | 72.04 | 144088323 | 5 | 72.04 |
| 2021 | 2022 | Equity Share | 125.00 | 72.03 | 144060153 | 5 | 72.03 |
| 2020 | 2021 | Equity Share | 125.00 | 55.39 | 110781153 | 5 | 55.39 |
| 2019 | 2020 | Equity Share | 125.00 | 55.37 | 110735003 | 5 | 55.37 |
| 2018 | 2019 | Equity Share | 125.00 | 55.34 | 110686203 | 5 | 55.34 |
| 2017 | 2018 | Equity Share | 125.00 | 55.32 | 110630453 | 5 | 55.32 |
| 2016 | 2017 | Equity Share | 125.00 | 55.27 | 110548028 | 5 | 55.27 |
| 2015 | 2016 | Equity Share | 125.00 | 55.25 | 110508903 | 5 | 55.25 |
| 2014 | 2015 | Equity Share | 125.00 | 55.04 | 110072903 | 5 | 55.04 |
| 2013 | 2014 | Equity Share | 125.00 | 54.88 | 109751153 | 5 | 54.88 |
| 2012 | 2013 | Equity Share | 125.00 | 54.79 | 109583403 | 5 | 54.79 |
| 2011 | 2012 | Equity Share | 125.00 | 54.72 | 109435903 | 5 | 54.72 |
| 2010 | 2011 | Equity Share | 125.00 | 54.72 | 109435903 | 5 | 54.72 |
| 2009 | 2010 | Equity Share | 125.00 | 54.72 | 109435903 | 5 | 54.72 |
| 2008 | 2008 | Equity Share | 125.00 | 54.72 | 109435903 | 5 | 54.72 |
| 2007 | 2007 | Equity Share | 125.00 | 54.72 | 109435903 | 5 | 54.72 |
| 2006 | 2006 | Equity Share | 125.00 | 54.72 | 109435903 | 5 | 54.72 |
| 2005 | 2005 | Equity Share | 100.00 | 54.65 | 109299601 | 5 | 54.65 |
| 2004 | 2004 | Equity Share | 100.00 | 54.50 | 108996006 | 5 | 54.50 |
| 2003 | 2003 | Equity Share | 60.00 | 36.30 | 36295852 | 10 | 36.30 |
| 2002 | 2002 | Equity Share | 60.00 | 36.27 | 36265252 | 10 | 36.27 |
| 2001 | 2001 | Equity Share | 60.00 | 36.26 | 36261652 | 10 | 36.26 |
| 2000 | 2000 | Equity Share | 60.00 | 36.26 | 36261652 | 10 | 36.26 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis